| 1 | [SID99494853] | Active | AC50 | 3.43 | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity [AID652116, Type: confirmatory] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | AC50 | 3.43 [uM] | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652116 | | BioAssay type | confirmatory | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 2 | [SID99494853] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID99494853] | Active | AC50 | 22.25 | Identification of Inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_Dose_CherryPick_Activity [AID651657, Type: confirmatory] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | AC50 | 22.25 [uM] | | BioAssay | Identification of Inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651657 | | BioAssay type | confirmatory | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 4 | [SID99494853] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 5 | [SID99494853] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 6 | [SID99494853] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 7 | [SID99494853] | Active | | | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID651710, Type: screening] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 651710 | | BioAssay type | screening | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 8 | [SID99494853] | Active | | | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity [AID602329, Type: screening] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Active | | BioAssay | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602329 | | BioAssay type | screening | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 9 | [SID99494853] | Inactive | Potency | 11.2202 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID99494853] | Inactive | | | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells [AID602274, Type: screening] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells | | AID | 602274 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID99494853] | Inactive | | | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity [AID602340, Type: screening] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity | | AID | 602340 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID99494853] | Inactive | | | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity [AID602363, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity | | AID | 602363 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID99494853] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID99494853] | Inactive | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID99494853] | Inactive | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID99494853] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID99494853] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID99494853] | Inactive | | | uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay [AID651582, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay | | AID | 651582 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID99494853] | Inactive | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID99494853] | Inactive | | | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity [AID651640, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity | | AID | 651640 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID99494853] | Inactive | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID99494853] | Inactive | AC50 | | Identification of Rad54 Inhibitors - Ruling Out Compounds That Bind DNA Measured in Biochemical System Using Plate Reader - 2159-04_Inhibitor_Dose_CherryPick_Activity [AID651673, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | AC50 | [uM] | | BioAssay | Identification of Rad54 Inhibitors - Ruling Out Compounds That Bind DNA Measured in Biochemical System Using Plate Reader - 2159-04_Inhibitor_Dose_CherryPick_Activity | | AID | 651673 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID99494853] | Inactive | AC50 | | Cytotoxicity assay Measured in Cell-Based System Using Plate Reader - 2159-05_Inhibitor_Dose_CherryPick_Activity [AID651692, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | AC50 | [uM] | | BioAssay | Cytotoxicity assay Measured in Cell-Based System Using Plate Reader - 2159-05_Inhibitor_Dose_CherryPick_Activity | | AID | 651692 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID99494853] | Inactive | | | HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity [AID651654, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651654 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID99494853] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID99494853] | Inactive | | | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library [AID651702, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library | | AID | 651702 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID99494853] | Inactive | AC50 | | RAD52: DNA binders Measured in Biochemical System Using Plate Reader - 7018-02_Inhibitor_Dose_CherryPick_Activity [AID652128, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | AC50 | [uM] | | BioAssay | RAD52: DNA binders Measured in Biochemical System Using Plate Reader - 7018-02_Inhibitor_Dose_CherryPick_Activity | | AID | 652128 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 29 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 30 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 31 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 32 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 33 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 34 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 35 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 36 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 37 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 38 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 39 | [SID99494853] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 40 | [SID99494853] | Inactive | | | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651636, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651636 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 41 | [SID99494853] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 42 | [SID99494853] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 43 | [SID99494853] | Inactive | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 44 | [SID99494853] | Inactive | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 45 | [SID99494853] | Inactive | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 46 | [SID99494853] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 47 | [SID99494853] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 48 | [SID99494853] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 49 | [SID99494853] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 50 | [SID99494853] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99494853 | | CID | 46948235 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|